MediWound DSMB sees no safety issues, backs EscharEx Phase III venous leg ulcer trial continuing unchanged
MDWD•DSMB review finds no safety concerns in Phase III trial
MediWound reported an independent DSMB review found no safety concerns in its Phase III VALUE trial of EscharEx for venous leg ulcers.
- No efficacy results were presented; the DSMB recommended the study continue without modification.
- Interim sample-size reassessment remains scheduled; patient enrollment completion is still expected by end of Q1 2027.
